USF-LVHN SELECT
Serum Tumor Markers for Muscle-Invasive Bladder Cancer in Clinical Practice: A Narrative Review.
Publication/Presentation Date
2-21-2025
Abstract
In recent decades, serum tumor markers (STMs) have emerged as valuable adjuncts in early cancer detection and post-treatment surveillance. STMs are inexpensive, minimally invasive, and readily accessible tools that can be used to diagnose cancers, monitor patients' responses to treatment, and even detect recurrence without imposing additional burdens on patients. Emerging evidence has demonstrated the reliability of STMs in the prognostication of bladder cancer (BC). However, their potential role extends beyond prognostication. This review intends to provide a multidimensional picture of STM applications in muscle-invasive bladder cancer (MIBC). In addition, we supplement this review with real-life clinical experiences from our institution to further illustrate the clinical feasibility of STMs in MIBC.
Volume
17
Issue
5
ISSN
2072-6694
Published In/Presented At
Doshi, C., Zahir, M., Dadabhoy, A., Escobar, D., Xia, L., & Daneshmand, S. (2025). Serum Tumor Markers for Muscle-Invasive Bladder Cancer in Clinical Practice: A Narrative Review. Cancers, 17(5), 728. https://doi.org/10.3390/cancers17050728
Disciplines
Medical Education | Medicine and Health Sciences
PubMedID
40075577
Department(s)
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students
Document Type
Article
